Open Water Rx review

This is a flat-rate seller that publishes its whole price list, and the list is more complete than most. Every program carries a one-, three- and six-month total, the monthly figure covers the clinician review, the medication and shipping, and the site says plainly that the price does not rise as your dose does. If you expect to titrate upward, that is the reassuring structure: the bill in month four is the bill in month one. If you intend to stay small it is the least economical one, because a quarter dose is charged what a full dose is. The detail that matters most here is the named microdosing protocol, sold beside the standard semaglutide plan at a slightly higher monthly figure. The low-dose product is the premium one, so if you want a small amount and choose the product labeled for it, you pay more than you would asking for a low dose inside the standard plan. The rest of the presentation is better than average: the pharmacy network is named, oral tablets of both molecules are priced, and the footer links the primary trial publications and the FDA's own shortage database rather than paraphrasing them. What is still missing is the milligram. No figure says how much drug it buys, so the flat-rate promise is accurate but cannot be checked against a dose.

Vs median

$6/mo below the $175 median across the 299 of 548 programs here that publish a plain monthly rate

Market

$59–$1,300/mo is the full published spread on this site

Structure

Same price at every dose

Consult

Included in the price

Dietitian

Not confirmed

Labs

Not required

Pricing

Flat at every dose

Open Water Rx names its pharmacy: Emerald · Stryker · Foothills · EPIQ Scripts. No bloodwork is required before you start. A clinician review is included in the price.

This is a flat-rate seller that publishes its whole price list, and the list is more complete than most. Every program carries a one-, three- and six-month total, the monthly figure is stated to cover the clinician review, the medication and shipping, and the site says plainly that the price does not rise as the dose does. For a reader expecting to titrate upward that is the reassuring structure: the bill in month four is the bill in month one. For a reader intending to stay small it is the least economical one, because a quarter dose is charged what a full dose is. The detail that matters most on this page is the named microdosing protocol, which is sold beside the standard semaglutide plan at a slightly higher monthly figure. The low-dose product is the premium one, so someone who wants a small amount and chooses the product labeled for it pays more than they would asking for a low dose inside the standard plan. That is worth knowing before picking by name. The rest of the presentation is better than average: the pharmacy network is named, oral tablets of both molecules are priced, and the footer links the primary trial publications and the FDA's own shortage database rather than paraphrasing them. What is still missing is the milligram. No figure on the site says how much drug it buys, which leaves the flat-rate promise accurate but impossible to check against a dose.

The named microdose line costs more a month than the standard semaglutide plan.

• No milligram sits behind any figure.
• Payment is taken at signup, before the provider review, and refunded if you are not prescribed.

Open Water Rx is one of 548 low-dose GLP-1 programs compared on this site, and 299 of them publish a monthly rate you can read before signing up. The full list puts every published price in one place, with the companies that pay us listed first — something we state there, on the page it applies to.

Intentional GLP-1 microdosing is off-label and unproven — no randomized trial has established that a sub-label dose does anything, and any dose belongs with a clinician who knows your history. If you are going to have that conversation, have it with real numbers.

• What microdosing GLP-1 costs
• Microdosing tirzepatide
• What the evidence actually shows
• The true annual cost of a plan